Title: Management of glaucoma Part I. Primary angle closure glaucoma Part II. Primary open-angle glaucoma
Edition: Adapted
Classification: Standard guideline
Field: Comprehensive guideline
Countries and regions: Saudi Arabia
Guidelines users: Physicians, nurses, pharmacists and technicians in the ophthalmology department.
Evidence classification method: The description of the methodology for the production of this adapted CPG can be fulfilled by utilizing the King Saud University (KSU) Modified ADAPTE method. This CPG formal adaptation method included three phases (setup, adaptation, and finalization), nine modules, and 24 steps with modifications in the steps and tools to suit the local general healthcare setting in Saudi Arabia. Overall, the steps of CPG adaptation included the selection of the health topic, formulation of the CPG adaptation working group, identification of health questions using the PIPOH model, searching and selecting Source CPGs with clear inclusion and exclusion criteria, quality assessment of included Source CPGs by using the Appraisal of Guidelines for Research and Evaluation (AGREE) II Instrument, assessment of the currency of the selected Source CPG, drafting of the adapted CPG, external review and consultation process, finalization of the adapted CPG with a set of implementation tools, declaration of conflicts of interests, and finally a plan for review and update. For further details on the specific modifications in steps and tools, refer to the article by Amer et al. 2019 (https://doi.org/10.1111/jep.12927).
Development unit: King Saud University Medical City (KSUMC)
Registration time: 2022-08-15
Registration number: PREPARE-2022CN503
Purpose of the guideline: To provide updated evidence-based recommendations for management of patients with Glaucoma and to support the concept of Individualized glaucoma treatment which aims at providing glaucoma management tailored to the individual needs of the patient for the concerned Healthcare providers in KAUH and King Khalid University Hospital in Riyadh, Saudi Arabia. Generally, the goal of glaucoma treatment is to maintain the patient’s visual function and related quality of life, at a sustainable cost. The cost of treatment in terms of inconvenience and side effects as well as financial implications for the individual and society requires careful evaluation. Quality of life is closely linked with visual function and overall patients with early to moderate glaucoma damage have good visual function and modest reduction in quality of life.